FSR has partnered with aTyr Pharma, Inc. to help inform patients about an ongoing clinical trial for ATYR1923, a potential new treatment for pulmonary sarcoidosis (ATYR1923-C-002, NCT03824392.) aTyr recently issued a press release, republished with permission below,...
There are many ways that patients can help advance sarcoidosis research and aid in finding a cure. For example, patients can host fundraisers in their hometowns, participate in clinical trials, and raise awareness about the disease. All of these efforts make a huge...
The Oregon Health and Science University is leading a new clinical trial, Tofacitinib for Prednisone Dependent Pulmonary Sarcoidosis Patients. The purpose of this study is to learn more about treatment of sarcoidosis in patients who currently require corticosteroids. ...
Scientists are working diligently to find the cause of sarcoidosis, but the answer is still unclear. They have uncovered evidence that suggests certain genetic and environmental factors are involved, but with so many factors coming into play, it is difficult to tell...
Patients are often looking for ways they can contribute to the advancement of research for their disease. Luckily, clinical trials are a great way for patients to get involved in the research process. As of now, clinical trials are the most effective way to obtain new...
Since sarcoidosis is a rare disease, doctors often lack the information they need in order to properly care for sarcoidosis patients. Scientists are working diligently to uncover the cause of sarcoidosis and develop a cure, but in the meantime, options for sarcoidosis...
Back in 2016, FSR began our Sarcoidosis Disease Model program with a Request For Applications for research projects that looked for a viable disease model for sarcoidosis. In the years since, we’ve awarded $1,050,000 towards multiple promising projects through a...
FSR awarded an additional $300,000 towards our Sarcoidosis Disease Model program.This recent award brings FSR’s total investment in finding a viable disease model for sarcoidosis to $1,050,000 to date.A major limiting factor in discovering new insights into the...
The Foundation of Sarcoidosis Research is pleased to announce the awardees for the Small Grant Program 2019 Cycle 1, Dr. Nisha Gilotra and Dr. Wonder Drake. FSR’s Small Grant Program funds various field-initiated proposals in clinical and basic science settings....